Healthcare

Supporting nurses by bridging the knowledge divide with evidence-based technology

Nurses are the backbone of Singapore’s healthcare system and they play an important role in transforming the healthcare industry. President Halimah...

Childhood vaccination to be subsidised in CHAS general practitioner clinics

Subsidies will be available in both polyclinics and CHAS clinics by end-2020.

Singapore medical device output grew 4.2% in June

The industry outperformed the output of the manufacturing sector, which fell 6.9%.

IFC proposes $34.72m funding for PE fund Quadria Capital

The healthcare-focused PE firm has a target fund size of $555.57m for its Fund II.

94% of firms attach international medical plans to healthcare programmes

This comes as employees seek more comprehensive plans to reduce out-of-pocket costs.

1,000sqm biochemical R&D hub opens in Singapore

It was built by NUS, Agilent Technologies, and National University Hospital.

Prudential ties up with telemedicine firm MyDoc to launch digital health app

Pulse will provide health tools and consultations for 11 markets in Asia.

Chinese healthcare revenue growth set to weaken

The plan by the State Council to cut high-value medical consumables prices deals a heavy blow.

Top three healthcare firms averaged total return at 31.2% in January-July 2019

These three firms’ average dividend yield came at 3.3% over the same period.

OrangeTee & Tie agents get access to telehealth services in Doctor Anywhere tie-up

Benefits include a partner rate for each consultation and medication delivery within three hours.

Genesis Healthcare launches wellness app

Users can receive lifestyle tips and health recommendations based on individual DNA.

Raffles Medical Group profits down 14.7% in H1

Operating revenue fell due to the promotion and building costs for its Chongqing hospital.

Temasek unit invests $5m in HC Surgical Specialists

It will be done through a 3-year 5.5% convertible bond at a conversion price of $0.54 per share.

Lonza's core profits rose 9.5% to $720.6m in H1

Its pharma biotech & nutrition segment recorded 10.8% sales growth.